Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Elutia Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 28 | 31 | +3 |
| Shares | 17.4M | 18.1M | +680.4K (+3.9%) |
| Value | $34.4M | $16.1M | −$18.3M (−53.3%) |
New holders (6)
Institutions that held Elutia Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,371,603 | $1.22M | 0.02% |
| Citadel Advisors LLC | 56,604 | $50.4K | 0.00% |
| Virtu Financial LLC | 29,598 | $26.0K | 0.00% |
| HRT Financial LP | 24,228 | $21.0K | 0.00% |
| UBS Group AG | 221 | $197 | 0.00% |
| Barclays PLC | 100 | $89 | 0.00% |
Sold out (3)
Institutions that held Elutia Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Kennedy Capital Management, Inc. | 195,399 | $386.9K |
| XTX Topco Ltd | 14,012 | $27.7K |
| Raymond James Financial Inc | 1,100 | $2.18K |